Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)
China
· Delayed Price · Currency is CNY 14.45
+0.09 (0.63%)
Apr 29, 2026, 3:00 PM CST
SHA:600161 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 28,573 | 32,310 | 40,536 | 50,983 | 39,103 | 39,767 | Upgrade
|
| Market Cap Growth | -30.23% | -20.29% | -20.49% | 30.38% | -1.67% | -23.98% | Upgrade
|
| Enterprise Value | 30,324 | 34,128 | 38,978 | 49,023 | 37,846 | 37,744 | Upgrade
|
| Last Close Price | 14.45 | 16.34 | 20.23 | 25.32 | 19.38 | 19.63 | Upgrade
|
| PE Ratio | 26.27 | 29.62 | 26.17 | 45.94 | 44.39 | 52.33 | Upgrade
|
| Forward PE | 22.96 | 19.57 | 29.48 | 39.63 | 39.14 | 45.04 | Upgrade
|
| PS Ratio | 4.63 | 5.24 | 6.72 | 9.84 | 9.18 | 9.67 | Upgrade
|
| PB Ratio | 1.87 | 2.11 | 2.79 | 4.00 | 3.44 | 3.87 | Upgrade
|
| P/TBV Ratio | 2.78 | 3.14 | 4.20 | 5.69 | 4.78 | 5.27 | Upgrade
|
| P/FCF Ratio | - | - | - | 38.74 | - | - | Upgrade
|
| P/OCF Ratio | 84.35 | 95.38 | 49.45 | 21.30 | 34.73 | 40.56 | Upgrade
|
| PEG Ratio | - | 2.21 | 2.21 | 2.21 | 2.21 | 2.21 | Upgrade
|
| EV/Sales Ratio | 4.92 | 5.53 | 6.46 | 9.46 | 8.88 | 9.18 | Upgrade
|
| EV/EBITDA Ratio | 13.80 | 15.66 | 13.90 | 25.08 | 26.07 | 28.75 | Upgrade
|
| EV/EBIT Ratio | 17.03 | 19.16 | 15.77 | 28.73 | 29.27 | 32.15 | Upgrade
|
| EV/FCF Ratio | -113.66 | - | - | 37.25 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | 0.00 | 0.04 | 0.05 | Upgrade
|
| Debt / EBITDA Ratio | 0.07 | 0.07 | 0.02 | 0.02 | 0.27 | 0.38 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 0.03 | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.12 | -0.12 | -0.18 | -0.35 | -0.29 | -0.37 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.84 | -0.84 | -0.94 | -2.31 | -2.28 | -2.91 | Upgrade
|
| Net Debt / FCF Ratio | 6.86 | 6.86 | 10.63 | -3.43 | 14.52 | 25.25 | Upgrade
|
| Asset Turnover | 0.38 | 0.38 | 0.40 | 0.38 | 0.35 | 0.43 | Upgrade
|
| Inventory Turnover | 0.89 | 0.89 | 0.82 | 0.99 | 0.97 | 1.00 | Upgrade
|
| Quick Ratio | 4.06 | 4.06 | 3.41 | 3.66 | 4.25 | 6.65 | Upgrade
|
| Current Ratio | 8.00 | 8.00 | 6.89 | 5.92 | 6.28 | 9.32 | Upgrade
|
| Return on Equity (ROE) | 9.98% | 9.98% | 15.48% | 12.52% | 11.14% | 13.12% | Upgrade
|
| Return on Assets (ROA) | 6.86% | 6.86% | 10.28% | 7.87% | 6.59% | 7.68% | Upgrade
|
| Return on Invested Capital (ROIC) | 10.88% | 11.47% | 20.35% | 17.58% | 15.07% | 17.54% | Upgrade
|
| Return on Capital Employed (ROCE) | 11.50% | 11.50% | 16.80% | 13.20% | 11.00% | 10.90% | Upgrade
|
| Earnings Yield | 3.82% | 3.38% | 3.82% | 2.18% | 2.25% | 1.91% | Upgrade
|
| FCF Yield | -0.93% | -0.83% | -0.61% | 2.58% | -0.58% | -0.38% | Upgrade
|
| Dividend Yield | 1.39% | 1.22% | 0.49% | 0.49% | 0.21% | 0.35% | Upgrade
|
| Payout Ratio | 45.32% | 45.32% | 15.96% | 8.47% | 17.85% | 21.56% | Upgrade
|
| Buyback Yield / Dilution | 0.14% | 0.14% | -0.21% | 0.62% | -2.79% | -7.41% | Upgrade
|
| Total Shareholder Return | 1.52% | 1.36% | 0.28% | 1.12% | -2.57% | -7.06% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.